Christopher Mahoney
About Christopher Mahoney
Christopher Mahoney is a Senior Scientist II at MOMA Therapeutics in Boston, Massachusetts, where he has worked since 2019, focusing on drug discovery and target validation. With over a decade of experience in the biotechnology and pharmaceutical industries, he has previously held positions at Agios Pharmaceuticals and Third Rock Ventures.
Work at MOMA Therapeutics
Christopher Mahoney has been employed at MOMA Therapeutics as a Senior Scientist II since 2019. In this role, he focuses on drug discovery efforts that emphasize target identification and validation. His contributions include the development of novel therapeutic targets, which are critical to advancing the company's research initiatives. MOMA Therapeutics is located in Boston, Massachusetts, where Mahoney has played a significant role in the company's scientific endeavors.
Previous Experience at Agios Pharmaceuticals
Prior to his current position, Christopher Mahoney worked at Agios Pharmaceuticals as a Scientist from 2012 to 2019. During his seven years at Agios, he gained valuable experience in the biotechnology sector. His work involved various aspects of drug development and contributed to the company's research objectives. Agios Pharmaceuticals is known for its focus on innovative therapies for cancer and rare diseases.
Consulting Role at Third Rock Ventures
In 2019, Christopher Mahoney held a brief consulting position at Third Rock Ventures for one month. This role allowed him to leverage his expertise in the biotechnology field, although the specifics of his contributions during this time are not detailed. Third Rock Ventures is recognized for its focus on building innovative biotechnology companies.
Education and Expertise
Christopher Mahoney earned his degree from the University of Massachusetts Amherst, where he studied from 2001 to 2006. His educational background laid the foundation for his extensive expertise in the biotechnology and pharmaceutical industries. With over a decade of experience, Mahoney has developed a strong skill set in drug discovery, particularly in target identification and validation.
Background in Biotechnology and Pharmaceuticals
Christopher Mahoney has a robust background in the biotechnology and pharmaceutical industries, with experience spanning over ten years. His career includes significant roles in research and development, contributing to advancements in drug discovery and therapeutic target development. This extensive background positions him as a knowledgeable professional in his field.